Vitromac Pharma Private Limited
About Vitromac Pharma Private Limited
Data last updated:
Vitromac Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 07 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24230PN2019PTC187673. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Amit Gulabchand Oswal and Ranjit Dattatray Patil.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 1294 Wadki Tal Haveli New Telephone Exchange, Pune, Maharashtra, India – 412308.
As per the financials filed for FY 2021, the company reported a revenue of ₹1.11 Lakh. For the same year it recorded a net profit of ₹3,928 (net margin 3.5%) and EBITDA of ₹3,928 (EBITDA margin 3.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1294 Wadki Tal Haveli New Telephone Exchange, Pune, Maharashtra, India – 412308
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vitromac Pharma Private Limited
The main business activity of Vitromac Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vitromac Pharma Private Limited FY 2021 filings available
Vitromac Pharma Private Limited reported revenue of ₹1.11 Lakh for FY 2021.
Financial Statement Summary of Vitromac Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹3,928 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹3,928 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Vitromac Pharma Private Limited
| Metrics | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.5% | •••• |
| Net Profit Margin | 3.5% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vitromac Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vitromac Pharma Private Limited
Vitromac Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Reactionbox Engineering Private Limited | ₹1.14 Lakh (FY 2019) | •••• | •••• | -6.0% | •••• | Kamptee, Maharashtra, India |
| Cresscare Pharmaceuticals Private Limited | ₹1.13 Lakh (FY 2024) | •••• | •••• | 41.0% | •••• | Mumbai, Maharashtra, India |
| Miraki Glaze Private Limited | ₹1.13 Lakh (FY 2024) | •••• | •••• | -77.0% | •••• | Purnia, Bihar, India |
| Arabic Pharmaceuticals Private Limited | ₹1.12 Lakh (FY 2023) | •••• | •••• | 23.0% | •••• | Patna, Bihar, India |
| Effecta Therapeutics Private Limited | ₹1.11 Lakh (FY 2024) | •••• | •••• | 73.0% | •••• | Jaipur, Rajasthan, India |
| Vitromac Pharma Private Limited this company | ₹1.11 Lakh (FY 2021) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Virgoun Medsol Private Limited | ₹1.1 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Biowellson Healthcare Private Limited | ₹1.1 Lakh (FY 2025) | •••• | •••• | •••• | Gurgaon, Haryana, India | |
| Gwynieth Pharmaceutical Private Limited | ₹1.1 Lakh (FY 2024) | •••• | •••• | •••• | Kanpur, Uttar Pradesh, India | |
| Zencon Pharma Private Limited | ₹1.1 Lakh (FY 2018) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Pepper Cosmetics Private Limited | ₹1.09 Lakh (FY 2024) | •••• | •••• | 675.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Vitromac Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Vitromac Pharma Private Limited
Vitromac Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Gulabchand Oswal | Director | 07 Nov 2019 | 6 Years 11 Months | Current |
| Ranjit Dattatray Patil | Director | 07 Nov 2019 | 6 Years 11 Months | Current |
| Ashish Sopan Valhekar | Director | 07 Nov 2019 | 6 Years 11 Months | Current |
Ownership and Shareholding of Vitromac Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vitromac Pharma Private Limited
Vitromac Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Vitromac Pharma Private Limited
Employment history and EPFO contributions of people linked to Vitromac Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Vitromac Pharma Private Limited
Vitromac Pharma Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Amit Gulabchand Oswal was appointed as Director on 07 Nov 2019.
Credit Ratings, Litigation & Regulatory Alerts for Vitromac Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vitromac Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vitromac Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vitromac Pharma Private Limited
Vitromac Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vitromac Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vitromac Pharma Private Limited
Vitromac Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 07 November 2019 (7+ years old) and is registered under CIN U24230PN2019PTC187673.
Vitromac Pharma reported revenue of ₹1.11 Lakh for FY 2021.
Vitromac Pharma has 3 current directors:
- Amit Gulabchand Oswal - Director
- Ranjit Dattatray Patil - Director
- Ashish Sopan Valhekar - Director
Vitromac Pharma reported a net profit of ₹3,928 (net margin 3.5%) and EBITDA of ₹3,928 (EBITDA margin 3.5%) for FY 2021, as per its filed financial statements.
No. Vitromac Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Vitromac Pharma is U24230PN2019PTC187673. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vitromac Pharma was incorporated on 07 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Vitromac Pharma by revenue are Reactionbox Engineering Private Limited, Cresscare Pharmaceuticals Private Limited, Miraki Glaze Private Limited, Arabic Pharmaceuticals Private Limited, Effecta Therapeutics Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Amit Gulabchand Oswal was appointed as Director on 07 Nov 2019. Ashish Sopan Valhekar was appointed as Director on 07 Nov 2019. Ranjit Dattatray Patil was appointed as Director on 07 Nov 2019.
The registered office of Vitromac Pharma is at 1294 Wadki Tal Haveli New Telephone Exchange, Pune, Maharashtra, India – 412308.
Vitromac Pharma has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.